For the Inventor, By the Inventor

Enter assignee name

Abingdon, United Kingdom

Immunocore Limited

USPTO Granted Patents = 45

CIPO Patents = 7

EPO Patents = 36

Trademarks = 16

Forward Citations = 397

Loading Chart...

Loading Chart...

69 inventors (with patents filed for the assignee):

Bent Karsten Jakobsen (26 out of 32 patents)

Yi Li (14 out of 23 patents)

Peter Eamon Molloy (12 out of 17 patents)

4. Nathaniel Ross Liddy (11 out of 11 patents)

5. Annelise Brigitte Vuidepot (8 out of 8 patents)

6. Jonathan Michael Boulter (6 out of 9 patents)

7. Steven Mark Dunn (6 out of 9 patents)

8. Chandramouli Reddy Chillakuri (5 out of 5 patents)

9. Tara Mahon (5 out of 5 patents)

10. Alex Powlesland (4 out of 4 patents)

11. Stephen Harper (4 out of 4 patents)

12. Philip William Addis (4 out of 4 patents)

13. Dhaval Jaykant Sangani (3 out of 3 patents)

14. Graham Anthony Hood (3 out of 3 patents)

15. Lucy Boulter, Legal Representative (3 out of 3 patents)

Core Competencies:

Binding Molecules

T Cell Receptors

HIV Specific Binding Molecules

TCR Libraries

Bifunctional Polypeptides

High Affinity T Cell Receptors

Nucleic Acid Molecules

Modified T Cell Receptors

Peptides Derived from MHC Molecules

T Cell Receptor Display

Engineered Immune-Mobilizing T Cell Receptors

Soluble T Cell Receptors

45 patents: Sort by Forward Citations

1. 12195534 - Binding molecules (2025-01-14),

2. 12134647 - Binding molecules (2024-11-05),

3. 12103971 - HIV specific binding molecules (2024-10-01),

4. 12065475 - T cell receptors and fusion proteins thereof (2024-08-20),

5. 12018062 - T cell receptors (2024-06-25),

6. 11929151 - Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex (2024-03-12),

7. 11827688 - Dosing regimen for GP100-specific TCR—anti-CD3 SCFV fusion protein (2023-11-28),

8. 11739442 - TCR libraries (2023-08-29),

9. 11739441 - TCR libraries (2023-08-29),

10. 11718657 - T cell receptors (2023-08-08),

11. 11639374 - T cell receptors specific for the NY-ESO-1 tumor antigen-HLA-A*02 complex (2023-05-02),

12. 11505590 - T cell receptors (2022-11-22),

13. 11440944 - Engineered immune-mobilizing T-cell receptors with enhanced affinity for HIV-1 Gag (2022-09-13),

14. 11427624 - T cell receptors (2022-08-30),

15. 11136575 - TCR libraries (2021-10-05),

Immunocore Limited is a leading biotechnology company that specializes in the discovery and development of T cell receptor (TCR)-based immunotherapies for the treatment of cancer, infectious diseases, and autoimmune disorders. Their innovative platform utilizes the power of the immune system to target and eliminate diseased cells. With a strong focus on precision medicine, Immunocore aims to revolutionize the field of immunotherapy and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

45 Patents

#4 in Abingdon

#385 in United Kingdom

#14,979 in the World

Abingdon, United Kingdom

Immunocore Limited

Forward Citations = 397

69 inventors:

Bent Karsten Jakobsen (26 out of 32 patents)

Yi Li (14 out of 23 patents)

Peter Eamon Molloy (12 out of 17 patents)

4. Nathaniel Ross Liddy (11 out of 11 patents)

5. Annelise Brigitte Vuidepot (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…